Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Novozymes Biopharma's Technology Demonstrates Potential for Monthly Drug Dosing

January 28, 2014

Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.

Copley Scientific Launches Two New Products for MDI Testing

January 24, 2014

Products enable testing in accordance with methods described in new USP monograph.

Testosterone-Regulated Genes May Affect Vaccine Immunity

January 06, 2014

A study led by Stanford University explains why men may have weaker responses to vaccines than women.

Animal Vaccine Study May Advance HIV Vaccine Research

January 06, 2014

A monkey-vaccine study provides insight into HIV research.

ALpHA G Capsule Filter for Single-Use Systems

January 02, 2014

ALpHA G Capsule Filter for Single-Use Systems

Battling Off-Weight Tablets

January 02, 2014

Training, calibration, and preventive maintenance help prevent over-and under-weight tablets. The author discusses causes of off-weight tablets and best practices for tableting.

The Role of NMR and Mass Spectroscopy in Glycan Analysis

January 02, 2014

NMR analysis provides crucial structural information of synthesized glycans while LC-MS/MS is ideal for quantitation of free sugars in biological matrices.

Challenges and Strategies for the Downstream Purification and Formulation of Fab Antibody Fragments

January 02, 2014

Antibody fragments pose unique challenges in terms of recovery, purification, and formulation.

Q&A with Roger Hayes, MPI Research

January 02, 2014

Roger Hayes of MPI Research discusses highly potent drug development.

Early Communication with Regulators is Essential for SMEs

January 02, 2014

With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.